Article
Evaluation of 6β-Hydroxycortisol and 6β-Hydroxycortisone as Biomarkers for Cytochrome P450 3A Activity: Insight into Their Predictive Value for Estimating Oral Immunosuppressant Metabolism.
Journal of pharmaceutical sciences - 1 Oct 2015
Luo Xi, Zheng Liyun, Cai Ningfang, Liu Qing, Yang Shuang, He Xiaoai, Cheng Zeneng
Abstract excerpt
The combined clearance of endogenous 6β-hydroxycortisol and 6β-hydroxycortisone is suggested biomarker for in vivo cytochrome P450 3A (CYP3A) activity. We aimed to determine whether the combined clearance of these two markers together with information of biopharmaceutics classification system (BCS) of drugs could be used to predict CYP3A-mediated metabolism of immunosuppressants. The BCS of drug formulations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.